Cargando…

Reverse pharmacology for developing an anti-malarial phytomedicine. The example of Argemone mexicana

Classical pharmacology has been the basis for the discovery of new chemical entities with therapeutic effects for decades. In natural product research, compounds are generally tested in vivo only after full in vitro characterization. However drug screening using this methodology is expensive, time-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Simoes-Pires, Claudia, Hostettmann, Kurt, Haouala, Amina, Cuendet, Muriel, Falquet, Jacques, Graz, Bertrand, Christen, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266807/
https://www.ncbi.nlm.nih.gov/pubmed/25516845
http://dx.doi.org/10.1016/j.ijpddr.2014.07.001
_version_ 1782349062654132224
author Simoes-Pires, Claudia
Hostettmann, Kurt
Haouala, Amina
Cuendet, Muriel
Falquet, Jacques
Graz, Bertrand
Christen, Philippe
author_facet Simoes-Pires, Claudia
Hostettmann, Kurt
Haouala, Amina
Cuendet, Muriel
Falquet, Jacques
Graz, Bertrand
Christen, Philippe
author_sort Simoes-Pires, Claudia
collection PubMed
description Classical pharmacology has been the basis for the discovery of new chemical entities with therapeutic effects for decades. In natural product research, compounds are generally tested in vivo only after full in vitro characterization. However drug screening using this methodology is expensive, time-consuming and very often inefficient. Reverse pharmacology, also called bedside-to-bench, is a research approach based on the traditional knowledge and relates to reversing the classical laboratory to clinic pathway to a clinic to laboratory practice. It is a trans-disciplinary approach focused on traditional knowledge, experimental observations and clinical experiences. This paper is an overview of the reverse pharmacology approach applied to the decoction of Argemone mexicana, used as an antimalarial traditional medicine in Mali. A. mexicana appeared as the most effective traditional medicine for the treatment of uncomplicated falciparum malaria in Mali, and the clinical efficacy of the decoction was comparable to artesunate–amodiaquine as previously published. Four stages of the reverse pharmacology process will be described here with a special emphasis on the results for stage 4. Briefly, allocryptopine, protopine and berberine were isolated through bioguided fractionation, and had their identity confirmed by spectroscopic analysis. The three alkaloids showed antiparasitic activity in vitro, of which allocryptopine and protopine were selective towards Plasmodiumfalciparum. Furthermore, the amount of the three active alkaloids in the decoction was determined by quantitative NMR, and preliminary in vivo assays were conducted. On the basis of these results, the reverse pharmacology approach is discussed and further pharmacokinetic studies appear to be necessary in order to determine whether these alkaloids can be considered as phytochemical markers for quality control and standardization of an improved traditional medicine made with this plant.
format Online
Article
Text
id pubmed-4266807
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-42668072014-12-16 Reverse pharmacology for developing an anti-malarial phytomedicine. The example of Argemone mexicana Simoes-Pires, Claudia Hostettmann, Kurt Haouala, Amina Cuendet, Muriel Falquet, Jacques Graz, Bertrand Christen, Philippe Int J Parasitol Drugs Drug Resist Invited Article Classical pharmacology has been the basis for the discovery of new chemical entities with therapeutic effects for decades. In natural product research, compounds are generally tested in vivo only after full in vitro characterization. However drug screening using this methodology is expensive, time-consuming and very often inefficient. Reverse pharmacology, also called bedside-to-bench, is a research approach based on the traditional knowledge and relates to reversing the classical laboratory to clinic pathway to a clinic to laboratory practice. It is a trans-disciplinary approach focused on traditional knowledge, experimental observations and clinical experiences. This paper is an overview of the reverse pharmacology approach applied to the decoction of Argemone mexicana, used as an antimalarial traditional medicine in Mali. A. mexicana appeared as the most effective traditional medicine for the treatment of uncomplicated falciparum malaria in Mali, and the clinical efficacy of the decoction was comparable to artesunate–amodiaquine as previously published. Four stages of the reverse pharmacology process will be described here with a special emphasis on the results for stage 4. Briefly, allocryptopine, protopine and berberine were isolated through bioguided fractionation, and had their identity confirmed by spectroscopic analysis. The three alkaloids showed antiparasitic activity in vitro, of which allocryptopine and protopine were selective towards Plasmodiumfalciparum. Furthermore, the amount of the three active alkaloids in the decoction was determined by quantitative NMR, and preliminary in vivo assays were conducted. On the basis of these results, the reverse pharmacology approach is discussed and further pharmacokinetic studies appear to be necessary in order to determine whether these alkaloids can be considered as phytochemical markers for quality control and standardization of an improved traditional medicine made with this plant. Elsevier 2014-07-30 /pmc/articles/PMC4266807/ /pubmed/25516845 http://dx.doi.org/10.1016/j.ijpddr.2014.07.001 Text en © 2014 The Authors http://creativecommons.org/licenses/by-nc-sa/3.0/ This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).
spellingShingle Invited Article
Simoes-Pires, Claudia
Hostettmann, Kurt
Haouala, Amina
Cuendet, Muriel
Falquet, Jacques
Graz, Bertrand
Christen, Philippe
Reverse pharmacology for developing an anti-malarial phytomedicine. The example of Argemone mexicana
title Reverse pharmacology for developing an anti-malarial phytomedicine. The example of Argemone mexicana
title_full Reverse pharmacology for developing an anti-malarial phytomedicine. The example of Argemone mexicana
title_fullStr Reverse pharmacology for developing an anti-malarial phytomedicine. The example of Argemone mexicana
title_full_unstemmed Reverse pharmacology for developing an anti-malarial phytomedicine. The example of Argemone mexicana
title_short Reverse pharmacology for developing an anti-malarial phytomedicine. The example of Argemone mexicana
title_sort reverse pharmacology for developing an anti-malarial phytomedicine. the example of argemone mexicana
topic Invited Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266807/
https://www.ncbi.nlm.nih.gov/pubmed/25516845
http://dx.doi.org/10.1016/j.ijpddr.2014.07.001
work_keys_str_mv AT simoespiresclaudia reversepharmacologyfordevelopinganantimalarialphytomedicinetheexampleofargemonemexicana
AT hostettmannkurt reversepharmacologyfordevelopinganantimalarialphytomedicinetheexampleofargemonemexicana
AT haoualaamina reversepharmacologyfordevelopinganantimalarialphytomedicinetheexampleofargemonemexicana
AT cuendetmuriel reversepharmacologyfordevelopinganantimalarialphytomedicinetheexampleofargemonemexicana
AT falquetjacques reversepharmacologyfordevelopinganantimalarialphytomedicinetheexampleofargemonemexicana
AT grazbertrand reversepharmacologyfordevelopinganantimalarialphytomedicinetheexampleofargemonemexicana
AT christenphilippe reversepharmacologyfordevelopinganantimalarialphytomedicinetheexampleofargemonemexicana